Kalidex Pharmaceuticals' Series A Round

Kalidex Pharmaceuticals raised a round of funding on February 01, 2011.

Kalidex Pharmaceuticals is a privately held anti-infective company creating the next generation of quinolones to help address the global problem of emerging infections caused by MDR organisms. Kalidex…

Articles about Kalidex Pharmaceuticals' Series A Round: